LONGEVRA◆ LAB
Tirzepatide
GLP-1/GIP Dual Agonist · Lyophilized
PURITY≥ 99%
METHODHPLC
LOT2605-11
EXP2027-06
15 mg
99% PURE
HPLC VERIFIED
NET 15mg
FOR RESEARCH USE ONLY · NOT FOR HUMAN CONSUMPTION
Tirzepatide · LONGEVRA
LONGEVRA · RESEARCH GRADE

Tirzepatide (GLP-1/GIP) 15MG

Tirzepatide (GLP-1/GIP) 15MG

$105.00

For Research Use Only — Not for Human or Veterinary Consumption. Sold by Longevra Research LLC for laboratory use only. Not approved by the FDA. Not intended to diagnose, treat, cure, prevent, or mitigate any disease.

Tirzepatide is a synthetic peptide that activates two receptors at once: the GIP receptor and the GLP-1 receptor. Both belong to the incretin family. Most preclinical tirzepatide papers are asking whether dual-agonism produces a different downstream cAMP response than hitting either receptor alone.

What ships: 15MG per vial · ≥99% HPLC-verified purity · MS-confirmed identity · batch-specific Certificate of Analysis.

Category:
Bulk pricing — auto-applied at checkout
QuantityYou savePer unit
3+5%$99.75
5+10%$94.50
10+15%$89.25
Download Certificate of Analysis

Description

Tirzepatide is a synthetic 39-amino-acid peptide engineered as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. The molecule incorporates a C20 fatty di-acid side chain conjugated via a linker to enable albumin binding, a structural feature that has made it a subject of preclinical incretin research.

Research Context

Preclinical investigations have examined tirzepatide as a dual incretin receptor agonist in rodent and in vitro models. Laboratory studies have characterized the compound’s binding affinity, receptor activation profile, and downstream signaling at both GIP and GLP-1 receptors, with research interest in the unique pharmacology arising from simultaneous engagement of two incretin pathways. Researchers have used the peptide as a comparator in structure-activity studies alongside selective GLP-1 and selective GIP agonists, examining how dual engagement alters cAMP signaling, receptor internalization, and beta-arrestin recruitment in cell-culture models. This product is offered strictly as a research reagent for in vitro and preclinical metabolic biology workflows.

Reconstitution & Storage

  • Recommended reconstitution: 3 mL bacteriostatic water per 15 mg vial
  • Storage: Lyophilized: 2-8°C (refrigerated), long-term -20°C. Reconstituted: 2-8°C, use within 28 days.
  • Stability: Avoid freeze-thaw cycles. Protect from light.

Quality Specifications

Parameter Specification
Purity ≥99% (HPLC)
Identity Confirmed by mass spectrometry
Form Lyophilized powder
Vial size 15 mg
COA Included with order

Research Use Only Disclaimer

This product is sold strictly for laboratory and scientific research purposes. Not for human consumption, ingestion, or administration. Not intended to diagnose, treat, cure, or prevent any disease. Not approved by the FDA for any clinical use.

Reviews

There are no reviews yet.

Be the first to review “Tirzepatide (GLP-1/GIP) 15MG”

Your email address will not be published. Required fields are marked *